CCL2 Potentiates Inflammation Pain and Related Anxiety-Like Behavior Through NMDA Signaling in Anterior Cingulate Cortex

• Published in: Molecular neurobiology 2024-08, Vol.61 (8), p.4976-4991
• Main Authors: Guo, Huan, Hu, Wen-chao, Xian, Hang, Shi, Yun-xin, Liu, Yuan-ying, Ma, Sui-bin, Pan, Kun-qing, Wu, Sheng-xi, Xu, Li-yan, Luo, Ceng, Xie, Rou-gang
• Format: Article
• Language: English
• Subjects: Anxiety; Behavior; Biomedical and Life Sciences; Biomedicine; CC chemokine receptors; Cell Biology; Chemokines; Chronic pain; Cortex (cingulate); Excitatory postsynaptic potentials; Glutamatergic transmission; Glutamic acid receptors; Inflammation; Injection; Monocyte chemoattractant protein 1; N-Methyl-D-aspartic acid receptors; Nervous system; Neurobiology; Neurology; Neurons; Neurosciences; Pain; Pain perception
• ISSN: 0893-7648; 1559-1182; 1559-1182
• DOI: 10.1007/s12035-023-03881-z

Previous studies have shown that the C-C motif chemokine ligand 2 (CCL2) is widely expressed in the nervous system and involved in regulating the development of chronic pain and related anxiety-like behaviors, but its precise mechanism is still unclear. This paper provides an in-depth examination of the involvement of CCL2-CCR2 signaling in the anterior cingulate cortex (ACC) in intraplantar injection of complete Freund’s adjuvant (CFA) leading to inflammatory pain and its concomitant anxiety-like behaviors by modulation of glutamatergic N-methyl-D-aspartate receptor (NMDAR). Our findings suggest that local bilateral injection of CCR2 antagonist in the ACC inhibits CFA-induced inflammatory pain and anxiety-like behavior. Meanwhile, the expression of CCR2 and CCL2 was significantly increased in ACC after 14 days of intraplantar injection of CFA, and CCR2 was mainly expressed in excitatory neurons. Whole-cell patch-clamp recordings showed that the CCR2 inhibitor RS504393 reduced the frequency of miniature excitatory postsynaptic currents (mEPSC) in ACC, and CCL2 was involved in the regulation of NMDAR-induced current in ACC neurons in the pathological state. In addition, local injection of the NR2B inhibitor of NMDAR subunits, Ro 25-6981, attenuated the effects of CCL2-induced hyperalgesia and anxiety-like behavior in the ACC. In summary, CCL2 acts on CCR2 in ACC excitatory neurons and participates in the regulation of CFA-induced pain and related anxiety-like behaviors through upregulation of NR2B. CCR2 in the ACC neuron may be a potential target for the treatment of chronic inflammatory pain and pain-related anxiety.